Gland Pharma lists with 13.40% premium on the BSE

20 Nov 2020 Evaluate

Gland Pharma has debuted at Rs 1701.00 on the BSE, up by 201 points or 13.40% from its issue price of Rs 1500.00.

The scrip is currently trading at Rs 1790.85, up by 290.85 points or 19.39% from its issue price. It has touched a high and low of Rs 1850.00 and Rs 1701.00 respectively. So far 6.92 lakh shares were traded on the counter.

The offering, which was open for subscription between November 09, 2020 and November 11, 2020, was subscribed 2.06 times. The issue price was fixed at Rs 1500 per share i.e. at upper end of price band of Rs 1490-1500 apiece.

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in over 60 countries, including the US, Canada, Australia and India.

Gland Pharma Share Price

1644.85 -6.00 (-0.36%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.